Close

Achillion Pharma (ACHN) Gains as Bristol-Myers' HCV Trial Suspended

August 14, 2014 12:59 PM EDT Send to a Friend
Achillion Pharma (NASDAQ: ACHN) stock gained Thursday, climbing 7%. In the view of Wells Fargo analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login